V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250007422 | 250009736 | 1.65 | 61 | Palliative (P) | 2014-08-22 | 2014-08-22 | Rituximab | N | N | 250032011 | RUXOLITINIB |
| 250007423 | 250005212 | 1.68 | null | Palliative (P) | 2014-03-27 | 2014-04-11 | Chlorambucil | N | N | 250032027 | AZACITIDINE |
| 250007424 | 250005213 | 1.59 | null | Palliative (P) | 2016-07-05 | 2016-07-05 | BUSULFAN | 02 | null | 250032028 | IPM |
| 250007425 | 250009737 | 1.81 | 99.4 | Palliative (P) | 2016-06-05 | 2016-06-05 | RUXOLITINIB | N | null | 250032029 | RUXOLITINIB |
| 250007426 | 250009737 | 1.7 | 55 | Not known (9) | 2016-08-28 | 2016-08-28 | Busulfan Oral | N | null | 250032029 | CYTARABINE |
| 250007427 | 250012383 | 1.55 | 52.5 | Disease modification (D) | 2015-08-23 | 2015-08-23 | RUXOLITINIB | N | N | 250032031 | RUXOLITINIB |
| 250007428 | 250012383 | 1.57 | null | Palliative (P) | 2016-09-02 | 2016-09-12 | FEC 100 + DOCETAXEL | 02 | N | 250032031 | IMATINIB |
| 250007429 | 250005214 | 1.77 | 92.8 | Disease modification (D) | 2017-09-20 | 2017-09-27 | RUXOLITINIB | 02 | N | 250032036 | BUSULPHAN |
| 250007430 | 250005215 | 1.83 | 92.8 | Disease modification (D) | 2017-06-03 | 2017-06-03 | RUXOLITINIB | N | N | 250032037 | BENDAMUSTINE + RITUXIMAB |
| 250007431 | 250009738 | 0 | 73 | Disease modification (D) | 2014-02-07 | 2014-02-07 | PEG INTERFERON | N | N | 250032038 | TRIAL |
| 250007432 | 250005216 | 1.53 | null | Not known (9) | 2014-10-03 | 2014-10-03 | Rituximab | N | N | 250032039 | RITUXIMAB |
| 250007433 | 250009739 | 1.76 | 74.5 | Curative (C) | 2016-02-20 | 2016-02-23 | ANAGRELIDE + Hydroxycarbamide | N | Y | 250032041 | RUXOLITINIB |
| 250007434 | 250011614 | null | 82.1 | Adjuvant (A) | null | 2017-10-12 | RUXOLITINIB | N | N | 250032042 | RUXOLITINIB |
| 250007435 | 250005217 | null | null | Palliative (P) | 2018-03-21 | 2018-03-21 | RUXOLITINIB | 2 | N | 250032045 | BORTEZOMIB |
| 250007436 | 250005218 | 0 | 70 | Disease modification (D) | 2014-08-10 | 2014-08-10 | Busulfan Oral | N | N | 250032051 | RUXOLITINIB |
| 250007437 | 250005219 | 1.5 | 66 | Adjuvant (A) | 2017-03-02 | 2017-03-02 | CVP | 2 | N | 250032053 | RUXOLITINIB |
| 250007438 | 250005220 | 0 | 101 | Palliative (P) | 2016-11-23 | 2016-11-23 | BUSULFAN | N | N | 250032055 | CHOP R |
| 250007439 | 250009740 | 1.82 | 0 | Disease modification (D) | 2014-10-22 | 2014-10-24 | RUXOLITINIB | 02 | N | 250032056 | RUXOLITINIB |
| 250007440 | 250005221 | 1.68 | 0 | Palliative (P) | 2014-02-03 | 2014-02-03 | CHOP R - 21 days | Y | N | 250032059 | AZACITIDINE |
| 250007441 | 250005222 | 0 | 70.3 | Adjuvant (A) | 2013-10-20 | 2013-10-31 | Azacitidine | N | N | 250032063 | PEG INTERFERON |
| 250007442 | 250005223 | 0 | 0 | Palliative (P) | 2017-04-15 | 2017-04-15 | CYTARABINE | N | N | 250032064 | TRIAL |
| 250007443 | 250005224 | 1.74 | 50.5 | Palliative (P) | 2016-11-03 | 2016-11-03 | Azacitidine | 2 | null | 250032067 | INTERFERON |
| 250007444 | 250005225 | 1.75 | 87.2 | Adjuvant (A) | 2018-07-26 | 2018-08-20 | RUXOLITINIB | null | N | 250032069 | PEG INTERFERON |
| 250007445 | 250005226 | 0 | 61.7 | Palliative (P) | 2016-02-15 | 2016-02-15 | RUXOLITINIB | N | N | 250032071 | RUXOLITINIB |
| 250007447 | 250005228 | 1.77 | 62.2 | Curative (C) | null | 2013-02-25 | RUXOLITINIB | N | N | 250032076 | RUXOLITINIB |
| 250007448 | 250009741 | null | null | null | 2014-06-19 | 2014-06-19 | Azacitidine | N | N | 250032077 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 250007449 | 250009741 | 0 | 81.4 | Palliative (P) | 2014-12-22 | 2015-01-28 | INTERFERON | 02 | N | 250032077 | RUXOLITINIB |
| 250007450 | 250005229 | 1.73 | null | null | 2016-09-10 | 2016-09-23 | RUXOLITINIB | 02 | N | 250032081 | ANAGRELIDE |
| 250007451 | 250005229 | null | 59.2 | null | 2013-05-23 | 2013-05-23 | Busulfan Oral | 02 | N | 250032081 | PEG INTERFERON |
| 250007452 | 250005230 | 1.6 | 62.6 | Disease modification (D) | 2017-11-19 | 2017-11-23 | PEG INTERFERON | N | N | 250032085 | BUSULPHAN |
| 250007453 | 250005230 | 0 | 0 | Palliative (P) | 2016-03-19 | 2016-04-09 | RUXOLITINIB | N | N | 250032085 | NOT MATCHED |
| 250007454 | 250005230 | 1.72 | 0 | Disease modification (D) | 2014-10-25 | 2014-10-25 | Carboplatin + Etoposide iv&po | N | N | 250032085 | CISPLATIN + PACLITAXEL |
| 250007455 | 250005230 | 1.64 | null | Palliative (P) | 2018-01-31 | 2018-01-31 | Trial Unspecified | 01 | N | 250032085 | CISPLATIN + PACLITAXEL |
| 250007456 | 250005230 | 0 | 70 | Disease modification (D) | 2015-03-06 | 2015-03-19 | Rituximab | N | N | 250032085 | RUXOLITINIB |
| 250007457 | 250005230 | null | null | Curative (C) | 2014-08-13 | 2014-08-13 | ANAGRELIDE | null | N | 250032085 | BUSULPHAN |
| 250007458 | 250005231 | null | 0 | Palliative (P) | 2017-09-14 | 2017-09-14 | RUXOLITINIB | N | N | 250032103 | RUXOLITINIB |
| 250007459 | 250005232 | 1.52 | null | Palliative (P) | 2016-06-10 | 2016-10-15 | Rituximab | 2 | N | 250032104 | ANAGRELIDE |
| 250007460 | 250005233 | 1.69 | null | Palliative (P) | 2013-11-18 | 2013-11-18 | CVP | null | N | 250032108 | RUXOLITINIB |
| 250007461 | 250005233 | 1.61 | 0 | Curative (C) | 2017-06-19 | 2017-06-19 | RUXOLITINIB | N | N | 250032108 | RUXOLITINIB |
| 250007462 | 250005234 | null | null | null | 2008-06-28 | 2013-09-30 | RUXOLITINIB | N | N | 250032113 | TRIAL |
| 250007463 | 250009745 | null | 64 | Curative (C) | null | 2014-02-14 | Busulfan Oral | null | N | 250032114 | RUXOLITINIB |
| 250007464 | 250011617 | 1.74 | 82 | Neo-adjuvant (N) | 2013-03-15 | 2013-03-16 | RUXOLITINIB | N | N | 250032117 | RUXOLITINIB |
| 250007465 | 250011617 | 1.72 | 0 | Curative (C) | 2013-07-03 | 2013-07-03 | Busulfan Oral | N | N | 250032117 | GEMCITABINE |
| 250007466 | 250005235 | 1.62 | 65 | Palliative (P) | 2014-12-24 | 2014-12-31 | Rituximab | N | N | 250032120 | AZACITIDINE |
| 250007467 | 250005235 | 1.74 | 0 | Adjuvant (A) | 2015-10-01 | 2015-10-01 | RUXOLITINIB | N | N | 250032120 | ANAGRELIDE |
| 250007468 | 250005235 | 1.48 | null | Palliative (P) | 2015-09-24 | 2015-09-24 | RUXOLITINIB | 2 | N | 250032120 | RUXOLITINIB |
| 250007469 | 250005235 | 1.67 | null | Curative (C) | 2016-04-15 | 2016-04-15 | RUXOLITINIB | 01 | N | 250032120 | ANAGRELIDE |
| 250007470 | 250005236 | 1.73 | 58.3 | Disease modification (D) | 2016-01-19 | 2016-01-31 | Enzalutamide | N | N | 250032138 | RUXOLITINIB |
| 250007471 | 250005237 | 1.84 | null | Palliative (P) | 2013-03-04 | 2013-03-04 | RAVVA TRIAL | N | N | 250032143 | RUXOLITINIB |
| 250007472 | 250005238 | 0 | 0 | Disease modification (D) | 2014-10-01 | 2014-10-15 | RUXOLITINIB | 2 | N | 250032145 | ANAGRELIDE |